000 01406 a2200397 4500
005 20250514184011.0
264 0 _c20041122
008 200411s 0 0 eng d
022 _a0033-3158
024 7 _a10.1007/s00213-004-1789-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFarré, M
245 0 0 _aRepeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics.
_h[electronic resource]
260 _bPsychopharmacology
_cMay 2004
300 _a364-75 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aArea Under Curve
650 0 4 _aCross-Over Studies
650 0 4 _aDouble-Blind Method
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aN-Methyl-3,4-methylenedioxyamphetamine
_xadministration & dosage
650 0 4 _aPsychomotor Performance
_xdrug effects
650 0 4 _aSelective Serotonin Reuptake Inhibitors
_xadministration & dosage
700 1 _ade la Torre, R
700 1 _aMathúna, B O
700 1 _aRoset, P N
700 1 _aPeiró, A M
700 1 _aTorrens, M
700 1 _aOrtuño, J
700 1 _aPujadas, M
700 1 _aCamí, J
773 0 _tPsychopharmacology
_gvol. 173
_gno. 3-4
_gp. 364-75
856 4 0 _uhttps://doi.org/10.1007/s00213-004-1789-7
_zAvailable from publisher's website
999 _c14786903
_d14786903